Attwill Medical Solutions Inc

General

Total Cases1

Active Cases1

Patents--

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

attwillmedical.com

attwill-medical

attwill-medical

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/01/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023)
08/28/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	ORDER, Galderma's Motion For Default Judgment (D.I. 445 ) is DENIED WITHOUT PREJUDICE pending final resolution of the claims against the Individual Defendants. The Parties' Joint Motion To Seal (D.I. 457 ) is GRANTED IN PART and DENIED IN PART as follows: The Motion is GRANTED as to Galderma's proposed redactions; the Motion is DENIED as to the Individual Defendants' proposed redactions. The Parties' Joint Motion To Seal Their Motion To Seal (D.I. 458 ) is GRANTED IN PART and DENIED IN PART to the same extent as their Motion To Seal. On or before September 1, 2023, the Individual Defendants shall file unredacted versions of any materials for which I have denied leave to file under seal. (See Order for further details). Signed by Judge Joshua D. Wolson on 8/28/2023. (twk) (Entered: 08/28/2023) ORDER, Galderma's Motion For Default Judgment (D.I. 445 ) is DENIED WITHOUT PREJUDICE pending final resolution of the claims against the Individual Defendants. The Parties' Joint Motion To Seal (D.I. 457 ) is GRANTED IN PART and DENIED IN PART as follows: The Motion is GRANTED as to Galderma's proposed redactions; the Motion is DENIED as to the Individual Defendants' proposed redactions. The Parties' Joint Motion To Seal Their Motion To Seal (D.I. 458 ) is GRANTED IN PART and DENIED IN PART to the same extent as their Motion To Seal. On or before September 1, 2023, the Individual Defendants shall file unredacted versions of any materials for which I have denied leave to file under seal. (See Order for further details). Signed by Judge Joshua D. Wolson on 8/28/2023. (twk) (Entered: 08/28/2023)
08/17/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	Joint MOTION to Seal Document: 457 Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023)
08/17/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	[SEALED] Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exhibit A - Declaration of David Banchik, # 2 Exhibit B - Declaration of Joseph Mahoney, # 3 Exhibit 1 - 7-17-23 email, # 4 Exhibit 2 - redacted version of Ex. 6, # 5 Exhibit 3 - redacted version of Ex. 7, # 6 Exhibit 4 - redacted version of Ex. 65, # 7 Exhibit 5 - 7-19-23 email, # 8 Exhibit 6 - 7-20-23 email, # 9 Exhibit 7 - 7-21-23 email, # 10 Exhibit 8 - 8-9-23 email, # 11 Appendix 1 - Plaintiffs' Position, # 12 Appendix 2, part 1 - Individual Defendants' Position, # 13 Appendix 2, part 2 - Individual Defendants' Position, # 14 Appendix 3 - proposed redactions to Reply Brief)Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023) [SEALED] Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exhibit A - Declaration of David Banchik, # 2 Exhibit B - Declaration of Joseph Mahoney, # 3 Exhibit 1 - 7-17-23 email, # 4 Exhibit 2 - redacted version of Ex. 6, # 5 Exhibit 3 - redacted version of Ex. 7, # 6 Exhibit 4 - redacted version of Ex. 65, # 7 Exhibit 5 - 7-19-23 email, # 8 Exhibit 6 - 7-20-23 email, # 9 Exhibit 7 - 7-21-23 email, # 10 Exhibit 8 - 8-9-23 email, # 11 Appendix 1 - Plaintiffs' Position, # 12 Appendix 2, part 1 - Individual Defendants' Position, # 13 Appendix 2, part 2 - Individual Defendants' Position, # 14 Appendix 3 - proposed redactions to Reply Brief)Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023)
08/14/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Requests for Production, (2) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Angel Barraza y Del Toro's First Set of Requests for Production, (3) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Interrogatories, (4) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Angel Barraza y Del Toro's First Set of Interrogatories and (5) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Requests for Admission - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) (Entered: 08/14/2023) NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Requests for Production, (2) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Angel Barraza y Del Toro's First Set of Requests for Production, (3) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Interrogatories, (4) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Angel Barraza y Del Toro's First Set of Interrogatories and (5) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Requests for Admission - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) (Entered: 08/14/2023)
08/10/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	STIPULATION AND ORDER, The Parties will file the Joint Motion to Seal on or before August 17, 2023. (Notice of Compliance deadline set for 8/17/2023.) Signed by Judge Joshua D. Wolson on 8/10/2023. (apk) (Entered: 08/10/2023)
08/09/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	STIPULATION TO EXTEND TIME to file Joint Motion to Seal to August 17, 2023 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 08/09/2023)
08/03/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	ORDER, upon review of the docket, which shows that Plaintiff Galderma Laboratories L.P. filed its Opening Brief In Support Of Its Motion For Default Judgment (D.I. 446 ) and its Reply Brief In Support Of Its Motion For Default Judgment (D.I. 452 ) under seal, but did not file a motion to seal either brief, it is ORDERED that on or before August 10, 2023, Galderma Shall file a Motion to Seal both documents, in accordance with the governing Protective Order in this matter (D.I. 93 ). Signed by Judge Joshua D. Wolson on 8/3/2023. (mpb) (Entered: 08/03/2023) ORDER, upon review of the docket, which shows that Plaintiff Galderma Laboratories L.P. filed its Opening Brief In Support Of Its Motion For Default Judgment (D.I. 446 ) and its Reply Brief In Support Of Its Motion For Default Judgment (D.I. 452 ) under seal, but did not file a motion to seal either brief, it is ORDERED that on or before August 10, 2023, Galderma Shall file a Motion to Seal both documents, in accordance with the governing Protective Order in this matter (D.I. 93 ). Signed by Judge Joshua D. Wolson on 8/3/2023. (mpb) (Entered: 08/03/2023)